Skip to main content
. 2008 Oct 16;88(6):535–543. doi: 10.1007/s00277-008-0624-3

Fig. 1.

Fig. 1

Box plots (p < 0.001) indicating the range and mean values (thick black lines) of the Hb Winnipeg variant percentage between carriers bearing the HBA1 or HBA2 mutation. In our evaluation, the Hb Winnipeg/α-thalassemia compound heterozygous case, as well as the cases described in Ref. [32], is excluded